Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • MonaE
    Member
    • May 2013
    • 24

    Ion Torrent targeted sequencing

    Hello Every one,

    I am a new NGS user. I am starting to work on targeted sequencing using Ion Torrent technology.

    My targeted gene is BRCA1 and I have about 50 samples. The gene is 112 amplicon. I would like to know how many samples per run I can pool?

    Thank you for your help
  • jimmyinfrance
    Member
    • May 2011
    • 16

    #2
    That depends a little on your experiment, ie how big your amplicons are, if its germline somatic mutationd and which chip you want to use ie 314/316/318.
    FYI -- we have recently been testing Sabioscience (Qiagen) gene-read (multiplex PCR) for this type of targeted experiment, seems to work well. We estimate (guess-timate) that 48 samples should be reasonable on a 316 (200mbp) Ion run.

    Comment

    • MonaE
      Member
      • May 2013
      • 24

      #3
      Thank you for your replay.
      I was just wondering how do you do these calculations?

      I found out that if I used 318 I will get a coverage of 7,84 but should use tow chips as the chip takes 48 samples. on the other hand if I used 316 I will have a coverage of 1,57. My samples are DNA from blood, do I need still (big) coverage?

      Comment

      • jimmyinfrance
        Member
        • May 2011
        • 16

        #4
        Here's a back-of-the-envelope calculation (i.e. it's rough).

        Assuming that average amplicon size = 200 bp
        you have 112 amplicons,
        you want 100X seq coverage

        = 2,2 mbp/individual (ie 200bp X 112 amplicons X 100 fold).

        2,2 X 48 = 107 mbp total. ABout capacity of a 316 mbp

        Very rough though so maybe overestimate needed coverage in order to achieve the minimum you need (ie difference in amplicons, barcodes etc).

        Comment

        • MonaE
          Member
          • May 2013
          • 24

          #5
          Thank you

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            Yesterday, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 11:10 AM
          0 responses
          8 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          30 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          39 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Working...